首页> 外文期刊>Cell >Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody
【24h】

Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody

机译:交叉反应人抗体中和马尔堡病毒的结构基础

获取原文
获取原文并翻译 | 示例
           

摘要

The filoviruses, including Marburg and Ebola, express a single glycoprotein on their surface, termed GP, which is responsible for attachment and entry of target cells. Filovirus GPs differ by up to 70% in protein sequence, and no antibodies are yet described that cross-react among them. Here, we present the 3.6 angstrom crystal structure of Marburg virus GP in complex with a cross-reactive antibody from a human survivor, and a lower resolution structure of the antibody bound to Ebola virus GP. The antibody, MR78, recognizes a GP1 epitope conserved across the filovirus family, which likely represents the binding site of their NPC1 receptor. Indeed, MR78 blocks binding of the essential NPC1 domain C. These structures and additional small-angle X-ray scattering of mucin-containing MARV and EBOV GPs suggest why such antibodies were not previously elicited in studies of Ebola virus, and provide critical templates for development of immunotherapeutics and inhibitors of entry.
机译:包括Marburg和Ebola在内的线状病毒在其表面表达一种糖蛋白,称为GP,负责靶细胞的附着和进入。丝状病毒GP的蛋白质序列相差最多70%,并且尚未描述它们之间发生交叉反应的抗体。在这里,我们介绍了马尔堡病毒GP与来自人类幸存者的交叉反应抗体复合的3.6埃晶体结构,以及与埃博拉病毒GP结合的抗体的低分辨率结构。抗体MR78识别丝状病毒家族中保守的GP1表位,这很可能代表其NPC1受体的结合位点。确实,MR78阻断了必需NPC1结构域C的结合。这些结构以及含粘蛋白的MARV和EBOV GP的其他小角度X射线散射表明,为什么以前在埃博拉病毒研究中未引出此类抗体,并提供了关键的模板免疫疗法和进入抑制剂的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号